top of page

Xovoltib 40 mg Tablet

SKU Boehringer Ingelheim India Pvt Ltd
Prix d’origine

167,12$

Prix promotionnel

137,46$

Xovoltib 40 mg Tablet is a targeted therapy designed for adults diagnosed with advanced or metastatic non-squamous non-small cell lung cancer, serving as a crucial first-line treatment or an effective option following the failure of traditional chemotherapy. This innovative medication works by specifically inhibiting mutated forms of the epidermal growth factor receptor (EGFR), particularly in patients whose tumors harbor the exon 19 deletion or the L858R substitution mutation, thereby disrupting cancer cell growth and proliferation. It is important to note that Xovoltib is not recommended for use in children or adolescents, as its safety and effectiveness in these age groups remain unestablished. Patients considering Xovoltib should discuss their eligibility and any potential risks with their healthcare provider to ensure the best possible treatment outcomes. As with any cancer treatment, monitoring for side effects is essential, and patients should report any unusual symptoms promptly. By utilizing Xovoltib, individuals may experience a tailored approach to managing their lung cancer, enhancing their quality of life during treatment. Always consult a healthcare professional for more information and guidance on using this medication effectively.

Quantité

Active Pharmaceutical Ingredient

Afatinib 40 mg

Uses

• Xovoltib 40 mg tablet is primarily utilized in the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by the uncontrolled growth of cells in the lung tissue. By targeting specific pathways involved in cancer cell proliferation, Xovoltib 40 mg tablet helps to manage the disease effectively. Patients receiving this treatment may experience improved disease control and quality of life.
• In addition to its role in managing non-small cell lung cancer, Xovoltib 40 mg tablet can be part of a broader treatment regimen. It may be prescribed in combination with other therapies to enhance overall effectiveness. This strategic approach aims to address various aspects of the cancer and potentially improve patient outcomes. Healthcare providers often tailor the treatment plan based on individual patient needs and responses.
• The use of Xovoltib 40 mg tablet is particularly relevant for patients who have specific genetic mutations associated with NSCLC. By identifying these mutations, clinicians can determine the most appropriate use of this medication. This targeted therapy approach aims to inhibit cancer growth more effectively than traditional treatments. Thus, Xovoltib 40 mg tablet represents a significant advancement in personalized cancer care.
• Xovoltib 40 mg tablet is often employed in cases where other treatment options have been exhausted or are not suitable. It provides an alternative for patients who may not respond well to standard chemotherapy. The effectiveness of this medication in specific patient populations highlights its importance in lung cancer management. As a result, Xovoltib 40 mg tablet is a valuable option for those facing challenging treatment scenarios.

Benefits

Xovoltib 40 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Xovoltib 40 mg Strip can help to slow the progression of cancer. Afatinib Tablet 40 mg may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Xovoltib Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects

Like all medications, Xovoltib 40 mg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Decreased appetite
• Burning sensation during urination
• Fatigue
• Ankles and feet swelling.

Common Side Effects

• Vomiting
• Diarrhoea
• Mouth sores
• Acne
• Itchiness
• Rashes

How To Use

Xovoltib Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Xovoltib 40 mg exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Xovoltib 40 mg Tablet, contact your doctor immediately or seek medical help at the nearest hospital emergency department.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Xovoltib 40 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Xovoltib 40 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Xovoltib 40 mg Tablet is recommended. The use of Xovoltib 40 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Xovoltib 40 mg Tablet. Xovoltib 40 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Xovoltib 40 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Xovoltib 40 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Xovoltib 40 mg Tablet is recommended. The use of Xovoltib 40 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Xovoltib 40 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Xovoltib 40 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Xovoltib 40 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Xovoltib 40 mg.

bottom of page